Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic

 
This item is provided by the institution :

Repository :
Annals of Gastroenterology
see the original item page
in the repository's web site and access all digital files if the item*
share




2012 (EN)
Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic (EN)

Allard, Johane
Mouzaki, Marialena

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Nonalcoholicsteatohepatitis (NASH) reflects severe liver disease within the NAFLD spectrumand can progress to end-stage liver disease. Within this manuscript we review the availableevidence for the treatment of NASH as well as the newer therapeutic agents that are currentlybeing investigated.Keywords NASH, fatty liver, treatment, vitamin E, pioglitazoneAnn Gastroenterol 2012; 25 (2): 207-217 (EN)

info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

Ελληνική Γαστροεντερολογική Εταιρία (EL)
Hellenic Society of Gastroenterology (EN)

2012-06-22


Hellenic Society of Gastroenterology (EN)

1792-7463
1108-7471
Annals of Gastroenterology; Volume 25, No 3 (2012); 207 (EN)



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)